CPSA Europe 2021
“The point is that they could run a clinical trial at home, something we talk about all the time at CPSA.” – James Rudge, Neoteryx
Updated Forecasts. The conversation on behalf of the patient continues – highlighted by personal experiences and perspectives shared with the launch of CPSA Europe 2021 in February.
- Why is CPSA so important to the Patient?
- Plenary Lecture – James Rudge, Neoteryx
- Enabling early diagnosis and prevention of disease
- Imagine Summit – Jenny Royle, Rekaryo Health
- Putting the requirements of the patient (consumer) at the center
- Pre-Conference Workshop – New Objective and Spooner Bioanalytical Solutions
- Standardization and compatibility with patient centric sampling (low volume and longitudinal) to enable industrialization (for all)
- CPSA Charitable Foundation Quarterly Meeting
- A focus on the most desperate – A powerhost for rare disease and pediatrics (non-competitive collaboration)
- Early Career and Young Scientist – Sigrid Deprez, University of Ghent, Nithya Paranthaman, Institute of Cancer Research and Dan Baker, University of Hertfordshire
- Integrated Solutions – Simple. Easy. Scalable. – From Patent to Sample to Analytics to Data
- Plenary Lecture – James Rudge, Neoteryx
Perspective and Experience. Continuous improvement. Strategic approach. Benefit the patient.
- Define standards for new, integrated approaches
- Focus on most desperate
- Deliver 1-3 clinical trials per year
- Compare novel approaches with current gold standards
- Facilitate adoption of new standards
- Redefine standard of care
- Change the boundaries of health with individuals
- Early diagnosis and prevention of disease
- Data underpins the individual; drives healthcare; fuels innovation
- Current sampling and analytics features 20 mL blood
- The future is here – dedicated to the patient – sampling to feature 100 uL blood; solutions that are simple, integrated and scalable; and analytics redefined to be portable based on patient needs
- Logistics have to be reinvented
Quote to Value. Make sense of what is happening. Here are a few of quotes from our events from February. And more to come – during CPSA Europe 2021 and beyond; on behalf of the patient. Everyday.
- “The world is different to last year, and most definitely the last 10 years.” – James Rudge, Neoteryx
- “What we have now is to change the business… people can change the business (and pace of business).” – Jenny Royle, Rekaryo Health
- “CPSA Europe 2020 highlighted the challenges (perspectives from Fleur Chandler) to further analytical technology via connections.” – Dan Baker, University of Hertfordshire
- “We have learned the power of team work and just coming together and moving forward.” – Nithya Paranthaman, The Institute of Cancer Research
- “At each step; the next step becomes clearer.” – Emily Ehrenfeld, New Objective
- “In the regulated space… 21 days to get done.” – Hitesh Pandya, AstraZeneca
- “… key objective is to completely change healthcare; bring technology (portable solutions) closer to the patient.” – Sigrid Deprez, Ghent University
- “Maybe need to think about it differently.” – Matt Barfield, Roche
- “We think things are stopping us.” – Jenny Royle, Rekaryo Health
- “We have an opportunity.” – Neil Spooner, Spooner Bioanalytical Solutions
- “Why is not everyone using these technologies and solutions?” – Sigrid Deprez, Ghent University
Lessons Learned. It is our time to do something. Together. Everyday.